FDA Drug Safety Office Would Have $100 Mil. Budget Under Dodd Bill

The senator plans to introduce legislation that would establish a new FDA safety office dubbed the Office of Patient Protection. The OPP director would report to the FDA commissioner, and would have the authority to withdraw a drug from the market if it poses a safety risk.